APA (7th ed.) Citation

Benjamini, O., Rokach, L., Itchaki, G., Braester, A., Shvidel, L., Goldschmidt, N., . . . Tadmor, T. (2022). Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Haematologica (Roma), 107(3), 625-634. https://doi.org/10.3324/haematol.2021.279196

Chicago Style (17th ed.) Citation

Benjamini, Ohad, et al. "Safety and Efficacy of the BNT162b MRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia." Haematologica (Roma) 107, no. 3 (2022): 625-634. https://doi.org/10.3324/haematol.2021.279196.

MLA (9th ed.) Citation

Benjamini, Ohad, et al. "Safety and Efficacy of the BNT162b MRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia." Haematologica (Roma), vol. 107, no. 3, 2022, pp. 625-634, https://doi.org/10.3324/haematol.2021.279196.